Deep Pharma Intelligence (DPI) is a leading strategic and investment intelligence agency focused on the emerging markets in the Pharmaceutical, BioTech, and Healthcare Tech industries. DPI is producing regular analytical reports on major areas of high-potential in the pharmaceutical and healthcare industries, maintaining ratings of companies and governments based on their innovation potential and business activity in the BioTech space, and providing strategic consulting and investment intell ...
…
continue reading
Exploring all things genetics. Dr Patrick Short, University of Cambridge alumnus and CEO of Sano Genetics, analyses the science, interviews the experts, and discusses the latest findings and breakthroughs in genetic research. To find out more about Sano Genetics and its mission to accelerate the future of precision medicine visit: www.sanogenetics.com
…
continue reading
Digitally Curious is a show all about the near-term future with actionable advice from a range of global experts. Your host is leading Futurist and AI Expert Andrew Grill, a dynamic and visionary tech leader with over three decades of experience steering technology companies towards innovative success. Known for his captivating global keynotes, Andrew offers practical and actionable advice, making him a trusted advisor at the board level for companies such as Vodafone, Adobe, DHL, Nike, Nest ...
…
continue reading
1
EP 137: Mavis Machirori on promoting equity, diversity, and social justice in genomics research
41:40
41:40
Play later
Play later
Lists
Like
Liked
41:40
0:00 Intro 1:30 Mavis’ career arc, from starting as a midwife to researching medical innovation and technology with an emphasis on advocacy and equity 7:00 Systemic issues that are easily overlooked in medical research and advancements Webinar: Participant Diversity: Increasing the Impact of Biomedical Research Webinar 10:00 Addressing Eurocentrici…
…
continue reading
1
EP 136: Developments in ring chromosome 20 research and advocacy with Allison Watson
40:57
40:57
Play later
Play later
Lists
Like
Liked
40:57
0:00 Introduction 2:00 Allison’s personal journey to researching epilepsy and ring chromosome 20 syndrome 4:00 Biggest challenges families face with ring chromosome 20 syndrome 11:00 Incidence and prevalence of r(20) syndrome, and how we can improve data reliability 21:00 Applying next generation sequencing to r(20) syndrome gene research 29:00 Eng…
…
continue reading
1
EP 135: Integration of newborn sequencing programs into healthcare systems with Dr. Ingrid Holm
41:16
41:16
Play later
Play later
Lists
Like
Liked
41:16
0:00 Introduction 1:30 Ingrid’s initial interests in genetics, paediatrics, and newborn screening 2:45 How the original BabySeq project, a pioneering newborn sequencing program got started, how it’s going, and the launch of BabySeq2 8:45 Lessons from BabySeq1 and goals for BabySeq2 10:30 Potential societal and long-term considerations for those inv…
…
continue reading
1
S6 Episode 5: The next frontier for AI – introducing the AI PC – powered by Intel
56:03
56:03
Play later
Play later
Lists
Like
Liked
56:03
This episode is sponsored by Intel. There are some exciting new developments in AI, and we're at the beginning of a truly transformative era, thanks largely to innovations led by companies such as Intel. Intel's recent advancements in AI technology, particularly Intel vPro PCs powered by Intel Core Ultra processors, are setting a new benchmark for …
…
continue reading
1
EP 134: Prenatal genetic testing and the future of AI in genetic counselling with Kira Dineen, host of DNA Today
40:44
40:44
Play later
Play later
Lists
Like
Liked
40:44
0:00 Introduction 1:00 The backstory of how Kira first started DNA Today in 2012, when she was still in high school! 3:30 Some of Kira’s favourite topics she has discussed on DNA Today, including the legacy of Henrietta Lacks, and the story of a Glee actress with down syndrome 10:00 Kira’s best practices for podcasting, from over 10 years of experi…
…
continue reading
1
EP 133: Insights into pharmacogenomics and increasing diversity in genomics research with Dr. Emma Magavern
39:17
39:17
Play later
Play later
Lists
Like
Liked
39:17
0:00 Introduction 2:00 The value of an English Literature degree in designing and analysing research studies in medicine 3:45 Emma’s entrance to pharmacogenomics and her transition from practising physician to genetics research 6:00 How the East London Genes and Health program is increasing representation of diverse populations, namely South Asians…
…
continue reading
1
EP 132: From mammoths to genome editing, trailblazing genetics with Dr. George Church
47:41
47:41
Play later
Play later
Lists
Like
Liked
47:41
0:00 Introduction 1:00 George’s upcoming big projects, including developing full recycling, renewing energy, creating bioweather maps, and harnessing citizen science 6:45 Progress in engineering viral resistance in humans, including thoughts from pre- and post- pandemic 11:00 A swapped genetic code that prevents viral infections and gene transfer b…
…
continue reading
1
EP 131: The potential of somatic genomics in drug discovery and development with Jake Rubens
44:57
44:57
Play later
Play later
Lists
Like
Liked
44:57
0:00 Intro 0:40 Jake’s experiences as a serial entrepreneur starting five companies with a basis in genomic science 5:30 Opportunities for research and drug development in the realm of somatic science 9:20 Somatic evolution and how it provides valuable insights into disease mechanisms 12:30 Advantages and disadvantages of studying germline genome-w…
…
continue reading
1
EP 130: Quarterly insights into noncoding variants and GWAS with Dr. Veera Rajagopal
51:56
51:56
Play later
Play later
Lists
Like
Liked
51:56
Show Notes: 0:00 Introduction 1:20 How polydactyl mutations can inform research on non-coding variant mechanisms The importance of low-affinity binding between transcription factors and targets How these lessons can help us improve our understanding of drug and target discovery See Veera’s January round-up for more information: https://www.gwasstor…
…
continue reading
1
EP 129: Patient advocacy for genetic ALS and FTD with Jean Swidler, Executive Director of End the Legacy
38:44
38:44
Play later
Play later
Lists
Like
Liked
38:44
0:00 Introduction 0:45 Jean’s personal experiences with family members with genetic ALS 10:00 Jean’s thoughts on the barriers and facilitators to providing treatment for those with genetic ALS 13:20 Insights into C9orf72, a common genetic determinant of ALS, and how it can also be associated with FTD 16:10 Jean’s experiences as an active advocate f…
…
continue reading
1
EP 128: Parkinson’s disease and precision medicine with Drs. James Beck and Ignacio Mata
50:18
50:18
Play later
Play later
Lists
Like
Liked
50:18
0:00 Introduction 1:05 Insights into the PD GENEration’s (a programme from the Parkinson's Foundation) milestones and progress points for the upcoming year 3:30 The shifting attitudes and perspectives of neurologists and healthcare workers at the PD GENEration 5:50 Insights into Nacho’s work with the genetics of Parkinson’s disease 10:20 Barriers a…
…
continue reading
1
EP 127: Insights into precision medicine, fatty liver disease, and minimally invasive diagnostic tools with Dr. Mazen Noureddin
39:10
39:10
Play later
Play later
Lists
Like
Liked
39:10
0:00 Intro 0:25 Mazen’s lifelong commitment to furthering the field of precision medicine in liver disease research, fueled by a personal connection of his grandmother developing MASH cirrhosis 2:30 Breakthroughs in the field of metabolic dysfunction-associated steatotic liver disease (MASLD) since the beginning of Mazen’s career 5:30 The potential…
…
continue reading
1
EP 126: Patient-led research for ultra-rare disease drug development with Julia Taravella, Executive Director of Rare Trait Hope Fund
39:41
39:41
Play later
Play later
Lists
Like
Liked
39:41
0:00 Introduction 0:25 Julia’s personal experience with ultra-rare diseases within her family 10:25 The importance of increasing accessibility to genetic testing across populations to learn more about ultra-rare diseases 14:00 The origin story of Rare Trait Hope Fund 23:50 Current research and next steps in developing potential gene therapies for a…
…
continue reading
1
EP 125: The future of UK Clinical Trial Policy: Innovation, integration, and game-changing legislation with Lord James O’Shaughnessy
45:23
45:23
Play later
Play later
Lists
Like
Liked
45:23
0:00 Introduction 1:25 How Lord O’Shaughnessy became involved in scientific policy making and his path to writing the UK Commercial Clinical Trials Review. 04:05 How Lord O’Shaughnessy pivoted from education to a focus on life sciences 06:38 The biggest challenges Lord O’Shaughnessy faced during his time as Parliamentary Under Secretary for Health …
…
continue reading
1
EP 124: How ReCode Therapeutics is pioneering tissue specific delivery of gene therapies for Primary Ciliary Dyskinesia with John Matthews
42:00
42:00
Play later
Play later
Lists
Like
Liked
42:00
0:00 Introduction 01:10 How growing up in Malawi planted the seeds for John’s career in medicine and transition to therapeutic development 04:35 Why John focuses on rare diseases and conditions such as asthma 06:01 What has changed over the last decade in terms of treating and understanding asthma and the progress that genetics has enabled 07:31 Wh…
…
continue reading
1
S6 Episode 4: The opportunity for Enterprise AI with Darshan Chandarana and Julia Howes from PWC
45:37
45:37
Play later
Play later
Lists
Like
Liked
45:37
This podcast episode features an interview with Darshan Chandarana and Julia Howes from PwC about opportunities in enterprise AI. They discussed AI adoption across industries, with financial services and retail leading the way, and Darshan emphasised the importance of responsible AI and understanding societal impacts. Julia discussed the challenges…
…
continue reading
1
EP 123: The ethics of newborn genome screening: Actionable insights and beyond with Holly Peay, Senior Research Scientist at the Research Triangle Institute
45:34
45:34
Play later
Play later
Lists
Like
Liked
45:34
0:00 Introduction 0:50 Holly’s background and career so far 03:30 Complex decision-making and multiple risk factors: Family history, genetics, phenotypes and beyond 07:05 Changes within the last decade to help people make complex, sometimes subjective, healthcare decisions 09:20 Impact on people: The RTI’s mission and the Early Check Study 13:45 Ne…
…
continue reading
1
EP 122: Building genome-scale engineered cells for biotechnology with Leslie Mitchell, Co-founder and CEO of Neochromosome
35:55
35:55
Play later
Play later
Lists
Like
Liked
35:55
Summary: 0:00 Introduction 01:01 How Leslie got into the field of synthetic biology and engineering, and her career journey so far 02:45 What Leslie accomplished during her postdoc and recent transformations in the field of genomics 05:57 The impacts of non-coding regions of the genome and the outcome of deletions 08:20 How long it takes to make ch…
…
continue reading
1
S6 Episode 3: Living in the moment - the opportunity for 5G Standalone with Nicki Lyons from Vodafone UK
19:30
19:30
Play later
Play later
Lists
Like
Liked
19:30
In this episode, we look at a report I wrote in partnership with Vodafone UK to examine how 5G Standalone (5G SA) could transform UK over the next 5-7 years. To talk more about the findings, I spoke with Nicki Lyons, Vodafone UK's Chief Corporate Affairs & Sustainability Officer. Some of the predictions in the report include: We’ll see the end of V…
…
continue reading
1
EP 121: Breakthroughs and insights in ALS research with Dr. Michael Benatar
44:10
44:10
Play later
Play later
Lists
Like
Liked
44:10
Summary: 0:00 Introduction 0:50 Reflections from the 34th International Symposium on ALS/MND in Basel 1:50 Michael’s professional journey, initial challenges he encountered, and how the field of neurology has evolved over the years 3:10 An introduction to the ALS landscape, including its presentation, the genes involved, and potential treatment opt…
…
continue reading
1
EP 120: Exploring the frontiers of gene therapy and AAVs with Dr. Nicole Paulk, CEO and Founder of Siren Biotechnology
43:47
43:47
Play later
Play later
Lists
Like
Liked
43:47
0:00 Introduction to Dr. Nicole Paulk, a pioneer in AAV research and the founder of Siren Biotechnology 0:50 The moments that shaped Nicole’s career path and her passion for gene therapy and AAV research 9:20 Nicole’s academic research career and her transition from academia to the biotech industry 23:00 The story behind the founding of Siren Biote…
…
continue reading
1
S6 Episode 2: Celebrating Facebook's 20th Anniversary: Facebook @ 20 with Jason Mander from GWI
33:36
33:36
Play later
Play later
Lists
Like
Liked
33:36
In this episode, we’re casting our minds back to 2004, when NASA landed the Spirit rover on Mars; the last episode of Friends aired; George W Bush was re-elected US president, and the number one hits were LMC’s Take Me To The Clouds Above in the UK and Hey Ya! By Outkast in the US. Over at Harvard University, computer science student Mark Zuckerber…
…
continue reading
1
EP 119: Revolutionising drug discovery: how the Pharma Proteomics Project is combining genetic and proteomic data with Chris Whelan
38:25
38:25
Play later
Play later
Lists
Like
Liked
38:25
0:00 Introduction 01:00 Chris’ background and career to date 02:10 What is the Enigma Project? 04:48 How is genetics being applied to drug discovery today and how does proteomics fit in? 09:23 When the UKBiobank Pharma Proteomics Project began and how long it took to set up 10:57 54k UK Biobank participants tested - discussion of findings 14:33 The…
…
continue reading
1
EP 118: The role of genetics in drug discovery and development with Dr. Matt Nelson
42:56
42:56
Play later
Play later
Lists
Like
Liked
42:56
Summary: 0:00 Introduction 5:45 Lessons learned from 15 years at GSK: How has genetics and drug discovery evolved over time? 8:10 Matt’s seminal 2015 paper: Quantifying the impact of human genetic evidence on the probability of success in drug development 11:40 Which types of genetic evidence are the best drivers of success in clinical trials? 13:3…
…
continue reading
1
S6 Episode 1: The new Y2K? Quantum computing and the threat of Q-Day in 2030 with Chris Johnson from Nokia
21:02
21:02
Play later
Play later
Lists
Like
Liked
21:02
Twenty-four years ago, the world prepared for the risk of a global meltdown due to the "Y2K bug" - the potential for computer errors related to the formatting and storage of calendar data for dates in and after the year 2000. The issue at the time was many programs represented four-digit years with only the final two digits, making the year 2000 in…
…
continue reading
1
EP 117: Wendy Chung: whole genome newborn screening and other big opportunities in genomic medicine.
47:51
47:51
Play later
Play later
Lists
Like
Liked
47:51
Summary: 0:00 Introduction 1:45 Wendy’s early career looking into the genetics of diabetes through mouse models 6:23 A high altitude view: Cutting through hype to spot the next wave of game-changing technology 8:03 The role of policy and communication: how Wendy’s work goes beyond the lab to create real-world impact 11:20 Wendy’s choice to do an MD…
…
continue reading
1
EP 116: Genetics and Medicine: Clonal hematopoiesis, genomics in healthcare, and a new discovery in APOL1 kidney disease with Dr. Alex Bick
52:34
52:34
Play later
Play later
Lists
Like
Liked
52:34
0:00 Introduction 4:23 Insights into clonal hematopoiesis from the pioneering Framingham Heart Study 8:30 Linking clonal hematopoiesis to cancer and cardiovascular health 11:22 Interplay of germline and somatic variants in clonal expansion 17:20 How the rate of clonal expansion can provide insights into cancer and cardiovascular risk 19:00 How clon…
…
continue reading
1
EP 115: The Biggest Stories of 2023 with Dr. Veera Rajagopal (Part 2)
1:35:11
1:35:11
Play later
Play later
Lists
Like
Liked
1:35:11
In the second instalment of our annual round-up episode, we welcome back Dr. Veera Rajagopal to cover the biggest stories in genetics and precision medicine of the last 12 months. Don’t forget to give the first instalment of our 2023 round-up a listen. Veera is a scientist at Regeneron with an interest in human genetics and drug target discovery in…
…
continue reading
1
EP 114: The Biggest Stories of 2023 with Dr. Veera Rajagopal (Part 1)
1:10:35
1:10:35
Play later
Play later
Lists
Like
Liked
1:10:35
0:00 Introduction 1:30 Veera’s personal highlights of 2023 Publication in Nature Genetics: Rare coding variants in CHRNB2 reduce the likelihood of smoking, an exome-wide association study identifying rare coding variants in CHRNB2 that may reduce the likelihood of smoking. Designing cover art Genetic links to neural circuits and their role in addic…
…
continue reading
1
EP 113: Harnessing human genetics to discover co-evolved small molecule medicines with Dr. Jason Park, CEO of Empress Therapeutics
44:31
44:31
Play later
Play later
Lists
Like
Liked
44:31
In this episode of The Genetics Podcast, we welcome Dr. Jason, founder and CEO of Empress Therapeutics, a Flagship Pioneering company. Join us as we discuss how human genetics can identify small molecules with therapeutic potential that are already created by our bodies, paving the way for faster discovery of new medicines. Summary: 0:00 Intro 1:20…
…
continue reading
1
EP 112: Making the leap: the scientists collaborating to transform genetic targets into next generation treatments, with David Ochoa
41:36
41:36
Play later
Play later
Lists
Like
Liked
41:36
This week on The Genetics Podcast Patrick is joined by David Ochoa, Platform Coordinator at Open Targets. They discuss how the Open Targets platform is enabling game-changing collaboration between academic research and big pharma. Working with partners including Sanofi, GlaxoSmithKline, Bristol Myers Squibb, Genentech and Pfizer, Open Targets power…
…
continue reading
1
EP 111: Combining human and machine intelligence in protein engineering with Dr. James Field, CEO of LabGenius
35:34
35:34
Play later
Play later
Lists
Like
Liked
35:34
In this episode of The Genetics Podcast, we welcome Dr. James Field, founder and CEO of LabGenius. Join us as we delve into LabGenius' cutting-edge approach that utilises machine learning, artificial intelligence, and sophisticated robotics to advance antibody discovery and drug development. As a bonus, learn about James’ path from scientist to CEO…
…
continue reading
1
S5 Episode 26: The Transformative Impact of Edge Computing with Mark Swinson from Red Hat
27:23
27:23
Play later
Play later
Lists
Like
Liked
27:23
Curious about edge computing? Want to understand why it's the next big thing in the world of IT? My conversation with Mark Swinson, an enterprise IT Automation Sales Specialist at Red Hat, might just be the discussion you're looking for. Mark takes us on a deep dive into the world of edge computing, discussing its benefits, applications, and the cr…
…
continue reading
1
EP 110: Educating the next generation of genomics talent, and the intersection of genetics and environment in cancer with Barbara Kraatz Fortini
35:41
35:41
Play later
Play later
Lists
Like
Liked
35:41
On this episode of The Genetics Podcast we welcome Dr. Barbara Kraatz Fortini, Associate Professor of Genetics at Keck Graduate Institute (KGI). Tune in to learn about Barbara's research on non-coding variants in colorectal cancer and the interplay between genetics and the environment on lifetime cancer risk. As the Program Director for the MS in H…
…
continue reading
1
S5 Episode 25: The Future of Multicloud Technology: A Deep Dive with Steve Young of Dell Technologies
43:40
43:40
Play later
Play later
Lists
Like
Liked
43:40
On this episode of the Actionable Futurist Podcast, I had an in-depth conversation with Steve Young, UK SVP & Managing Director for Dell Technologies, on why it is now critical that CEOs, CIOs, CFOs and CISOs play a role in driving a well-planned multicloud strategy for their businesses. In recent years, cloud technology has proliferated. However, …
…
continue reading
1
EP 109: From the Archives: Professor Sir Rory Collins on the Origins and Future of the UK Biobank
34:58
34:58
Play later
Play later
Lists
Like
Liked
34:58
This week, we’re re-sharing one of our favorite episodes from the early days of The Genetics Podcast - one that many newer listeners may not have heard! Tune in as Professor Sir Rory Collins, Founder and Chief Executive of the UK Biobank, talks to us about the origins and evolution of this world-changing project that has catalysed a wave of new dis…
…
continue reading
1
EP 108: Drug Development in Liver Disease: Breakthroughs, Challenges, and Insights with Dimitar Tonev
35:32
35:32
Play later
Play later
Lists
Like
Liked
35:32
In this episode of The Genetics Podcast, we're joined by Dimitar Tonev, an experienced drug development consultant specialising in Hepatology and Virology. Tune in to discuss the recent reclassification of Non-alcoholic Steatohepatitis (NASH) to Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), and the complexities of identifying tr…
…
continue reading
1
EP 107: Integrating Genomics and Individualised Medicine into the Mayo Clinic Healthcare System with Dr. Konstantinos Lazaridis
28:43
28:43
Play later
Play later
Lists
Like
Liked
28:43
In this episode of The Genetics Podcast, we welcome Dr. Konstantinos Lazaridis, the Executive Director of the Center for Individualized Medicine at the Mayo Clinic. Tune in to learn about the impacts of genomics and individualised medicine on rare liver diseases and advanced cancers . Discover how the Mayo Clinic actively uses genomic testing, prec…
…
continue reading
1
S5 Episode 24: Transforming the Legal Industry: The Role and Impact of AI with Jaeger Glucina from Luminance
27:23
27:23
Play later
Play later
Lists
Like
Liked
27:23
The world of law is not immune to the sweeping changes brought about by technological advancements, specifically the advent of Artificial Intelligence. In a fascinating discussion with Jaeger Glucina, Chief of Staff at Luminance, we delve into how AI is reshaping the legal industry and creating new possibilities for efficiency and accuracy in legal…
…
continue reading
1
S5 Episode 23: Shaping the Future of Enterprise-Grade AI with Umesh Sachdev of Uniphore
45:04
45:04
Play later
Play later
Lists
Like
Liked
45:04
Imagine a world where AI seamlessly integrates into your daily workflows, driving productivity gains, efficiency increases, and automation. AI and in particular Generative AI is all over the media, and now companies are looking at how they should be introducing AI into the enterprise. While Generative AI platforms such as ChatGPT have been trained …
…
continue reading
1
Ep 106: The Colliding World of Rare and Common Disease Genetics with Caroline Wright, Professor of Genomic Medicine at Exeter University
26:29
26:29
Play later
Play later
Lists
Like
Liked
26:29
In this episode, Patrick welcomes Caroline Wright, a leading expert in genomic medicine and Professor of Genomic Medicine at Exeter University. Listen in as they delve into the world of rare diseases, discussing the challenges in diagnosis, uses of population cohorts and, the potential of newborn screening. Caroline shares her excitement about new …
…
continue reading
1
S5 Episode 22: Navigating the World of General Artificial Intelligence with Peter Voss from Aigo.ai
19:03
19:03
Play later
Play later
Lists
Like
Liked
19:03
Can machines really think like humans? What is the future of General Artificial Intelligence (GAI) when machines more closely resemble human behaviour than ever before? In this episode, Peter unveils his journey into the realm of General Artificial Intelligence (GAI) and his vision of machines possessing the ability to think, learn, and reason like…
…
continue reading
1
S5 Episode 21: The Ethics and Implications of Data Privacy in the Digital World with Anton Christodoulou from Imagination
24:51
24:51
Play later
Play later
Lists
Like
Liked
24:51
In the race to dominate Al we have seen our data privacy, democracy, and even our human rights impacted. To understand what brands and consumers need to do to fight back, I spoke with Anton Christodoulou, Group Chief Technology Officer at leading experiential design company, Imagination and co-founder of the new Trust 3.0 initiative. The Trust 3.0 …
…
continue reading
1
EP105: Warren Huff, CEO and Chairman of Reata Pharmaceuticals, shares perspectives on provocative biology and the development of treatments for rare diseases
47:29:00
47:29:00
Play later
Play later
Lists
Like
Liked
47:29:00
In this episode, Patrick welcomes J. Warren Huff, CEO and Chairman of Reata Pharmaceuticals. Reata is known for innovating small-molecule therapies for severe and life-threatening diseases. Listen in as Warren walks us through their approach of partnering with Universities to find scientific discoveries that could become the next generation of ther…
…
continue reading
1
S5 Episode 20: Unraveling the Future of Self-Sovereign Identity with Marie Wallace from Accenture
38:10
38:10
Play later
Play later
Lists
Like
Liked
38:10
Consumers are beginning to understand that their personal data has real value, but it is still held in the hands of big technology companies. The promise of consumers managing and owning their own data will become a reality thanks to decentralised or self-sovereign identity (SSI). To delve into this topic, I'm delighted to welcome onto the podcast …
…
continue reading
1
EP104: Assessing the clinical utility of Polygenic Risk Scores in cancer screening with Professor Clare Turnbull
43:49:00
43:49:00
Play later
Play later
Lists
Like
Liked
43:49:00
Join Patrick Short and Professor Clare Turnbull, Professor in Translational Cancer Genetics at the Institute of Cancer Research, as they discuss polygenic risk scores and their application in healthcare. Delve into the complexities of predicting disease, the challenges of screening programs, and the potential impact of integrating genomics into hea…
…
continue reading
1
EP103: Gene Writing with Tessera Therapeutics CEO, Dr. Mike Severino
43:33:00
43:33:00
Play later
Play later
Lists
Like
Liked
43:33:00
In this episode, Patrick is joined by Dr. Mike Severino, CEO of Tessera Therapeutics and CEO-Partner of Flagship Pioneering. Join us as Mike walks us through Tessera’s approach to treating genetic diseases by rewriting bases, exons, or even whole genes with a novel approach called Gene Writing. 0:00 Intro1:00 What prompted you to join Flagship Pion…
…
continue reading
1
EP102: Dr. Marco Schmidt, founder and Chief Scientific Officer of BioTx.ai, on how to use artificial intelligence and machine learning in genomics research
37:36:00
37:36:00
Play later
Play later
Lists
Like
Liked
37:36:00
0:00 Intro0:45 The founding of BioTx.ai4:35 How do algorithms for ‘causal inference’ work?6:30 Modeling gene interactions for genetic disorders8:35 How to predict gene interactions 10:30 What happens after identifying a potential gene variant or interaction?14:35 How can you use machine learning to determine causal relationships between gene varian…
…
continue reading
1
EP101: Fostering international progress towards personalised medicine with Dr. Bettina Lundgren, CEO of the Danish National Genome Center
28:26:00
28:26:00
Play later
Play later
Lists
Like
Liked
28:26:00
Join Patrick in welcoming Dr. Bettina Lundgren, CEO of the Danish National Genome Center. Bettina is spearheading the development of personalised medicine in Denmark with a focus on integrating genome sequencing directly into the healthcare system. She is dedicated to fostering international collaboration in research and healthcare delivery. Tune i…
…
continue reading
1
S5 Episode 19: Unlocking Generative AI's Potential: Ethics, Creativity, and Impact - recorded LIVE at London Tech Week
44:17
44:17
Play later
Play later
Lists
Like
Liked
44:17
What if you could unlock the full potential of Generative AI and its impact on your life and company? Get ready for a fascinating fireside chat recorded live in front of an audience at the offices of leading international law firm RPC during London Tech Week. The Actionable Futurist Andrew Grill was interviewed on stage by Helen Armstrong, a Partne…
…
continue reading